Goldman Sachs’s Organigram Holdings OGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$766K Buy
571,369
+104,784
+22% +$156K ﹤0.01% 5288
2025
Q4
$784K Buy
466,585
+210,391
+82% +$362K ﹤0.01% 5300
2025
Q3
$520K Buy
256,194
+105,440
+70% +$166K ﹤0.01% 5488
2025
Q2
$204K Buy
+150,754
New +$184K ﹤0.01% 5660
2025
Q1
Sell
-168,754
Closed -$272K 6316
2024
Q4
$272K Buy
168,754
+21,700
+15% +$35.4K ﹤0.01% 5531
2024
Q3
$266K Buy
147,054
+35,599
+32% +$62K ﹤0.01% 5353
2024
Q2
$172K Buy
111,455
+5,252
+5% +$9.54K ﹤0.01% 5301
2024
Q1
$228K Buy
106,203
+73,523
+225% +$142K ﹤0.01% 5075
2023
Q4
$42.8K Hold
32,680
﹤0.01% 5396
2023
Q3
$43.1K Sell
32,680
-10,014
-23% -$15.1K ﹤0.01% 5294
2023
Q2
$266K Buy
42,694
+11,962
+39% +$23.1K ﹤0.01% 5069
2023
Q1
$78.7K Sell
30,732
-78,943
-72% -$250K ﹤0.01% 5488
2022
Q4
$351K Sell
109,675
-7,711
-7% -$29K ﹤0.01% 5060
2022
Q3
$409K Sell
117,386
-57,894
-33% -$242K ﹤0.01% 5103
2022
Q2
$642K Sell
175,280
-45,867
-21% -$234K ﹤0.01% 4909
2022
Q1
$1.47M Buy
221,147
+128,157
+138% +$791K ﹤0.01% 4512
2021
Q4
$651K Buy
92,990
+49,984
+116% +$424K ﹤0.01% 5187
2021
Q3
$396K Buy
43,006
+13,773
+47% +$141K ﹤0.01% 5337
2021
Q2
$335K Sell
29,233
-9,002
-24% -$102K ﹤0.01% 5454
2021
Q1
$531K Buy
38,235
+11,727
+44% +$136K ﹤0.01% 5070
2020
Q4
$141K Buy
26,508
+4,128
+18% +$21.2K ﹤0.01% 5205
2020
Q3
$94K Sell
22,380
-2,443
-10% -$12.7K ﹤0.01% 5099
2020
Q2
$155K Buy
24,823
+8,435
+51% +$56.8K ﹤0.01% 4884
2020
Q1
$131K Sell
16,388
-4,569
-22% -$41.5K ﹤0.01% 4875
2019
Q4
$205K Sell
20,957
-70,451
-77% -$832K ﹤0.01% 4885
2019
Q3
$1.26M Buy
91,408
+88,571
+3,122% +$1.86M ﹤0.01% 3878
2019
Q2
$73K Buy
+2,837
New +$78.8K ﹤0.01% 4977

Other funds holding OGI

Goldman Sachs's OGI Position: Q1 2026 in Review

Goldman Sachs increased its Organigram Holdings (OGI) stake by 22% in Q1 2026, buying an estimated $156K and bringing the position to 571,369 shares worth $766K. The position accounts for ﹤0.01% of the portfolio, ranked #5288.

Goldman Sachs first reported a position in OGI in Q2 2019 and has held it in 27 quarters since. The position peaked at $1.47M in Q1 2022. 73 funds tracked by Wall St. Rank hold OGI as of Q1 2026.

  • Goldman Sachs held 571,369 shares of Organigram Holdings worth $766K as of Q1 2026.
  • Goldman Sachs bought 104,784 Organigram Holdings shares in Q1 2026, an estimated $156K.
  • Organigram Holdings made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5288 holding.
  • Goldman Sachs first reported a position in Organigram Holdings in Q2 2019 and has held it in 27 quarters since.
  • Goldman Sachs's Organigram Holdings position peaked at $1.47M in Q1 2022.
  • 73 funds tracked by Wall St. Rank held Organigram Holdings as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.